source
- Weekly roundup highlights Biohaven’s challenge to Eli Lilly and industry competition with ChinaThe latest Endpoints Weekly issue focuses on a series of recent deals across the biotech sector, offering readers a snapshot of market activity. Among the items highlighted is Biohaven’s strategic…
- ARPA-H awards $160 M to accelerate bespoke gene‑editing therapies for rare diseasesARPA-H announced a $160 million, five‑year investment through its THRIVE program to speed the development of personalized gene‑editing treatments for rare genetic conditions. The awardees include…